WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015031709) RAPID ACTING INJECTABLE FORMULATIONS COMPRISING A PEPTIDE AND A VASODILATORY AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/031709    International Application No.:    PCT/US2014/053332
Publication Date: 05.03.2015 International Filing Date: 29.08.2014
IPC:
A61P 3/10 (2006.01), A61P 1/18 (2006.01), A61P 5/48 (2006.01), A61K 38/28 (2006.01), A61K 31/21 (2006.01)
Applicants: PEROSPHERE, INC. [US/US]; 20 Kenosia Avenue Danbury, CT 06810 (US)
Inventors: LAULICHT, Bryan, E.; (US).
BAKHRU, Sasha, H.; (US).
STEINER, Solomon, S.; (US)
Agent: OKUN, Jason M.; (US)
Priority Data:
61/872,185 30.08.2013 US
Title (EN) RAPID ACTING INJECTABLE FORMULATIONS COMPRISING A PEPTIDE AND A VASODILATORY AGENT
(FR) FORMULATIONS INJECTABLES À ACTION RAPIDE COMPRENANT UN PEPTIDE ET UN AGENT VASODILATATEUR
Abstract: front page image
(EN)A rapid acting injectable formulation is provided comprising a therapeutic peptide and a vasodilatory agent. The therapeutic peptide has a molecular weight of greater than about 500 Daltons, and the vasodilatory agent is present in an amount effective to increase the absorption of the therapeutic peptide. A method of increasing absorption of a therapeutic peptide by using such a formulation is also provided.
(FR)La présente invention concerne une formulation injectable à action rapide comprenant un peptide thérapeutique et un agent vasodilatateur. Le peptide thérapeutique présente un poids moléculaire supérieur à environ 500 uma, et l'agent vasodilatateur est présent dans une quantité efficace afin d'augmenter l'absorption du peptide thérapeutique. L'invention concerne également une méthode d'augmentation de l'absorption d'un peptide thérapeutique à l'aide d'une telle formulation.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)